Podcast
2024 Rewind: Most Memorable Quotes & Insights
Our team looked back on some of the most thought-provoking insights from conversations with key decision-makers in oncology. In this podcast episode, we explore the challenges and opportunities faced by oncologists, payers, and pathway developers.
Read MoreThe Latest
Article
Medicare Advantage Growth Will Bring Changes for Cancer Drug Manufacturers
Changes to Medicare, including Medicare Advantage, have important repercussions on patient access to care, oncologists’ treatment decisions, and drug manufacturers’ processes.
Lee Blansett
Article
Pharmacists’ Shifting Meeting Preferences
Welcome to the April 2023 edition of our Monthly Insight Series. This month we are evaluating the desire among oncology pharmacists to return to in-person meetings.
Cindy Chen
Article
Humana Quits Commercial
Welcome to the March 2023 edition of our Monthly Insight Series. This month we discuss how Humana terminated its employer group line of business and the implications.
Chris Van Denburg
Article
Anticipating Changes in the Community Oncology Ecosystem Through 2025
OneOncology’s $2 billion “for sale” sign is an important warning that the next 2 to 3 years will bring new, unpredictable shocks to the community oncology ecosystem as stakeholders grapple to assert control over the healthcare dollar.
Lee Blansett
Article
HMP Global Market Access Insights’ 2023 Research Year
We want to give you a look at some of the topics we’re planning to explore this year, as we enter yet another period of rapid change, upheaval, and uncertainty in 2023-2025.
Lee Blansett
Article
Community Oncology Providers and Value-based Care: Here’s What You Should Know
Welcome to the February 2023 edition of our Monthly Insight Series. This month we discuss how community oncology providers are engaging in value-based care.
Lee Blansett
Article
Oncology Value-based Care & Private Payers: What Exactly Is Going On?
Welcome to the January 2023 edition of our Monthly Insight Series. This month we discuss value-based care in oncology from a private-payer perspective.
Chris Van Denburg, Lee Blansett
Article
The Inflation Reduction Act: Here's What You Need to Know
Welcome to the December 2022 edition of our Monthly Insight Series. This month we highlight the Inflation Reduction Act of 2022 (IRA).
Cindy Chen, Lee Blansett
Article
In Case You Missed It: “Perspectives on Vertical Payers” Is Out Now!
Welcome to the October 2022 edition of our Monthly Insight Series. This month we discuss our new Perspectives on Vertical Payers report.
Chris Van Denburg
Article
Payer or Provider: Two Sides of the Same Coin?
Welcome to the September 2022 edition of our Monthly Insight Series. This month we discuss our inaugural Payer Report Series, which is launching soon.
Chris Van Denburg
Article
IDN Readout Roundup: Controls, Controls, and More Controls
Welcome to the June 2022 edition of our Monthly Insight Series. This month we highlight several queries that have generated lively discussions thus far.
Cindy Chen
Article
Routine Access for Cancer Drugs in IDNs: More Than Just a Click Away
Welcome to the May edition of our Monthly Insight Series. MAI conducts a Brand Survey as part of our annual IDN Trend Survey. For 2022, we continued this tradition as we set out to understand the prescribing burden for IDN oncologists.
Cindy Chen
Article
Moving Forward: Engaging With Oncology Pharmacy Providers
As we busily analyze field data collected from our annual IDN survey, we would like to offer a sneak peek at how oncology pharmacists want to engage with manufacturers in 2022 and beyond.
Cindy Chen
Article
Understanding HMP Global Market Access Insights' New Payer Report Series
Welcome to the March edition of our Monthly Insight Series. This month we review several highlights from our December 2021 Special Topic Report on Payers.
Chris Van Denburg